Mechanisms of Anabolic Therapies for Osteoporosis
- 30 August 2007
- journal article
- review article
- Published by Massachusetts Medical Society in The New England Journal of Medicine
- Vol. 357 (9), 905-916
- https://doi.org/10.1056/nejmra067395
Abstract
Antiresorptive agents help to restore skeletal balance by reducing bone turnover, primarily at the tissue level. Another therapeutic approach is to enhance bone formation with the use of anabolic agents, which differ fundamentally from antiresorptive drugs in their primary mechanism of action. This article reviews the mechanisms of polypeptide anabolic agents and strontium as potential therapeutic options for osteoporosis.Keywords
This publication has 73 references indexed in Scilit:
- Bone Quality — The Material and Structural Basis of Bone Strength and FragilityThe New England Journal of Medicine, 2006
- Regulation of bone mass by Wnt signalingJCI Insight, 2006
- Skeletal actions of insulin-like growth factorsExpert Review of Endocrinology & Metabolism, 2006
- The Fate of Circulating OsteoblastsThe New England Journal of Medicine, 2005
- Regulation of osteoblastogenesis and bone mass by Wnt10bProceedings of the National Academy of Sciences of the United States of America, 2005
- Mechanotransduction and strain amplification in osteocyte cell processesProceedings of the National Academy of Sciences of the United States of America, 2004
- Bone Remodeling Increases Substantially in the Years After Menopause and Remains Increased in Older Osteoporosis PatientsJournal of Bone and Mineral Research, 2004
- Bone Morphogenetic Proteins, Their Antagonists, and the SkeletonEndocrine Reviews, 2003
- The Bone Remodeling Compartment: A Circulatory Function for Bone Lining CellsJournal of Bone and Mineral Research, 2001
- Prevalence of Low Femoral Bone Density in Older U.S. Adults from NHANES IIIJournal of Bone and Mineral Research, 1997